Air pollution can trigger conditions such as acne, psoriasis, atopic dermatitis.(Pexels) ALSO READ: Doctor reveals air ...

MJH Life Sciences®, a premier provider of health care events, media, and education, today announced the acquisition of the Revolutionizing Atopic Dermatitis (RAD) Annual Meeting, a preeminent ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

Enhances Aclaris’ pipeline with complementary biologics portfolio -- Expands leadership team with addition of seasoned ...

BTIG analyst Julian Harrison upgraded the rating on Aclaris Therapeutics (ACRS – Research Report) to a Buy yesterday, setting a price target of ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

This compound comes in both form and gel form and garnered its first FDA approval in 2022. Zoryve is now approved to treat ...

Aclaris (ACRS) stock rallied 53% Monday after the company announced it had exclusively licensed two drug candidates from Biosion, prompting an upgrade by Piper Sandler.

Incyte has completed phase 2 trials of its X2 candidate in CIndU and atopic dermatitis. The analysts said the paused trial in ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...